Institutional investors purchased a net $1.4 million shares of DVAX during the quarter ended December 2017 and now own 73.55% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NORTHPOINTE CAPITAL LLC Bought 387.0 Thousand shares of Dynavax Technologies Corp